Pleuropericarditis related to the use of mesalamine

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Schroder H, Campbell DES: Absorption, metabolism, and excretion of salicylazosulphapyridine in man. Clin Pharmacol Ther 13:539–551, 1972

    Google Scholar 

  2. 2.

    Das KM, Dubin R: Clinical Pharmacokinetics of sulphasalazine. Clin Pharmacokinet 1:406–425, 1976

    Google Scholar 

  3. 3.

    Agnholt J, Soerensen HT, Rasmussen SN, et al: Cardiac hypersensitivity to 5-aminosalicylic acid. Lancet 2:1135, 1989

    Google Scholar 

  4. 4.

    Patwardhan RV, Heilpern J, Brewster AD, Darra JJ: Pleuropericarditis: An extraintestinal complication of inflammatory bowel disease. Arch Intern Med 143:94–96, 1983

    Google Scholar 

  5. 5.

    Barr-Locke D: Sulfasuxidine-induced lupus syndrome in a patient with Crohn's disease. Am J Gastroenterol 77:614–615, 1982

    Google Scholar 

  6. 6.

    Clementz GL, Dolin BJ: Sulfasalazine-induced lupus erythematosis. Am J Med 84:535–538, 1988

    Google Scholar 

  7. 7.

    Deboever G, Devogelaere R, Holvoet G: Sulfasalazine-induced lupus-like syndrome with cardiac tamponade in a patient with ulcerative colitis. Am J Gastroenterol 84:85–86, 1989

    Google Scholar 

  8. 8.

    FDA rare adverse reaction with Rowasa. FDA Drug Bull 19:17–18, 1989

    Google Scholar 

  9. 9.

    Kristensen KS, Hoegholm A, Bohr L, et al: Fatal myocarditis associated with mesalazine. Lancet 335:605, 1990

    Google Scholar 

  10. 10.

    Jenss H, Becker EW, Weber P: Pericardial effusion during treatment with 5-aminosalicylic acid in a patient with Crohn's disease. Am J Gastroenterol 85:332–333, 1990

    Google Scholar 

  11. 11.

    Sandberg-Gertzen H, Jarnerot G, Tysk C: Long-term treatment with olsalazine of ulcerative colitis: Safety and relapse prevention: A follow-up study. Scand J Gastroenterol 23:48–50, 1988

    Google Scholar 

  12. 12.

    Miner P, Hanauer S, Robinson M, et al: Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Dig Dis Sci 40:296–304, 1995

    Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Dr. Frank Friedenberg MD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Gujral, N., Friedenberg, F., Friedenberg, J. et al. Pleuropericarditis related to the use of mesalamine. Digest Dis Sci 41, 624–626 (1996). https://doi.org/10.1007/BF02282352

Download citation

Key words

  • mesalamine
  • inflammatory bowel disease
  • pericarditis
  • drug hypersensitivity